Cell free DNA for EGFR** Test
50+ booked in last 3 daysTest Overview
This test evaluates cell-free DNA (cfDNA) in the peripheral blood for the presence of the EGFR mutation in patients with non-small cell lung cancer (NSCLC) and can be used to assess eligibility for targeted therapies.
Frequently Asked Questions
Used to assess eligibility for targeted therapies.
Determination of EGFR mutation status in blood specimens as an alternative to invasive tissue biopsies.
This test evaluates cell-free DNA (cfDNA) in the peripheral blood for the presence of the EGFR mutation in patients with non-small cell lung cancer (NSCLC) and can be used to assess eligibility for targeted therapies.
Ratings & Reviews (0)
Why Metropolis?
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.